Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.
Neuropsychopharmacology · 2018
Last updated 2026-05-28Research in animals shows that a brain region called the lateral dorsal tegmental nucleus (LDTg) contains receptors for GLP-1, a hormone that reduces appetite. When these receptors are activated, either by natural signals or by GLP-1 drugs, it leads to smaller meals and less overall food intake without causing nausea. Blocking these receptors increases eating, and GLP-1 drugs given by injection can reach this brain area to further reduce food intake.
AI summary of the abstract below.
| Journal | Neuropsychopharmacology, 2018 |
|---|---|
| Citations | 46 |
| Relative citation ratio | 2.10 |
| NIH percentile | 75 |
| Molecules | — |
| Conditions studied | Obesity |
Abstract
The neurobiological substrates that mediate the anorectic effects of both endogenous glucagon-like peptide-1 (GLP-1) and exogenous GLP-1 receptor (GLP-1R) agonists are an active area of investigation. As the lateral dorsal tegmental nucleus (LDTg) expresses the GLP-1R and represents a potential neuroanatomical hub connecting the nucleus tractus solitarius (NTS), the major central source of GLP-1, with the other nuclei in the midbrain and forebrain, we tested the hypothesis that GLP-1R signaling in the LDTg controls food intake. Direct activation of LDTg GLP-1R suppresses food intake through a reduction in average meal size and independent of nausea/malaise. Immunohistochemical data show that GLP-1-producing neurons in the NTS project to the LDTg, providing anatomical evidence of endogenous central GLP-1 in the LDTg. Pharmacological blockade of LDTg GLP-1Rs with exendin-(9-39) dose-dependently increases food intake and attenuates the hypophagic effects of gastric distension. As GLP-1 mimetics are administered systemically in humans, we evaluated whether peripherally administered GLP-1R agonists access the LDTg to affect feeding. Immunohistochemical data show that a systemically administered fluorescent GLP-1R agonist accesses the LDTg and is juxtaposed with neurons. Additionally, blockade of LDTg GLP-1Rs attenuates the hypophagic effects of a systemic GLP-1R agonist. Together, these data indicate that LDTg GLP-1R signaling controls energy balance and underscores the role of the LDTg in integrating energy balance-relevant signals to modulate feeding.
Verbatim abstract via PubMed 28920591 ↗